I was given 16 months to live after being diagnosed with a rare cancer. Clinical trials gave me hope—and more time

I was given 16 months to live after being diagnosed with a rare cancer. Clinical trials gave me hope—and more time

Fact checked by Nick BlackmerPhoto courtesy of Katie Doble Katie Doble found treatment for her rare cancer by participating in clinical trials.Katie Doble was diagnosed with stage 1A ocular melanoma in the spring of 2013. Ocular melanoma is a rare type of cancer that develops in the eye, specifically in the melanin (pigment)-producing cells.At the time of Doble’s diagnosis, treatment options for her cancer were very limited. She underwent radiat…